Data Demonstrates Durability of Medtronic''s VenaSeal Closure System, a Non-Tumescent, Non-Thermal and Non-Sclerosant Procedure for Chronic Venous Insufficiency

12 month closure rates for the VenaSeal closure system comparable to radiofrequency ablation DUBLIN -- July 2, 2015 -- Medtronic plc (NYSE: MDT) today announced the twelve- month results of the VeClose pivotal study, which demonstrated the safety and effectiveness ...